Molecule could help treat insulin resistance

Diabetes Call for further research into apelin treatment in diabetes after positive results in mice.

Insulin resistance in diabetes and other metabolic disorders could be treated by a naturally occurring molecule with insulin-like effects, studies by French researchers suggest.

The mechanisms that regulate apelin, a peptide found in a variety of tissues in the body and in the bloodstream, and those that regulate insulin are known to be closely related, but researchers had not previously looked at how apelin affects glucose metabolism in the body.

Professor Isabelle Castan-Laurell and colleagues from the University of Toulouse injected mice intravenously with apelin and found that it rapidly reduced glucose levels in the blood.

They then went on to examine how apelin affected the way that glucose was metabolised in the body. They found that apelin increased glucose turnover and, in response, liver tissue adjusted its glucose production so that normal blood glucose levels were maintained.

In addition, apelin was able to increase insulin-stimulated glucose transport, suggesting that the effects of apelin and insulin are mediated by different mechanisms and can be additive.

'Apelin could represent a promising target in the management of insulin resistance,' Professor Castan-Laurell said.

'Improvement of insulin sensitivity and reduction of blood glucose levels are expected goals for the treatment of type-2 diabetes. We demonstrated that acute injection of apelin was able to improve glucose tolerance in insulin-resistant mice and to increase glucose utilisation in white adipose tissue, skeletal muscles and the heart.'

The effect of long-term treatment with apelin will now need to be studied to provide further insight into the precise role the peptide plays in treating insulin resistance, the researchers said.

The findings may also have wider benefits, they pointed out. 'The contribution of apelin should yield new insights into the physiology and physiopathology of glucose and lipid metabolism.'

tom.moberly@haymarket.com

Cell Metabolism 2008; 8: 437-45

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

The healthcare crisis in Myanmar - how UK GPs can help

The healthcare crisis in Myanmar - how UK GPs can help

Dr Jim Brockbank from Myanmar UK GP Health Action provides an update on how the military...

GPs warn of 'open floodgates' as 84% say e-consultations have driven up workload

GPs warn of 'open floodgates' as 84% say e-consultations have driven up workload

More than four fifths of GPs say e-consultation systems adopted in the pandemic have...

Map: Which CCGs have the highest COVID-19 vaccine coverage?

Map: Which CCGs have the highest COVID-19 vaccine coverage?

Tens of millions of COVID-19 jabs have been administered across England, but how...

Podcast: Greener practice, sharing patient data and additional roles

Podcast: Greener practice, sharing patient data and additional roles

In this episode we look at data extraction from GP records, ask whether the additional...

Red flag symptoms: Loss of consciousness

Red flag symptoms: Loss of consciousness

Red flag symptoms to look out for in presentations of loss of consciousness, including...

£20m fund to speed up second jabs as CCGs told to limit pressure on practices

£20m fund to speed up second jabs as CCGs told to limit pressure on practices

NHS England has announced £20m in funding to help local COVID-19 vaccination sites...